Colorectal cancer (CRC) is still the second most common cause of cancer death in the United States, despite the availability of a range of interventions to reduce the burden of CRC. Microsimulation modeling can inform policy makers in prioritizing among these cancer-control interventions. The CISNET-CRC team includes three collaborative modeling groups, each with a state-of-the-art, population-based microsimulation model for CRC: MISCAN, SimCRC, and CRC-SPIN. These three modeling groups have collaborated for eight years and have delivered a substantial body of policy-oriented work. We propose to continue this collaboration, further developing our models and using them to identify optimal cancer-control policies and practices to reduce the burden of CRC. Our proposed work centers around three specific aims.
In Aim 1 we extend our models to reflect the evolving understanding of the CRC disease processes and to incorporate new and updated screening modalities, allowing us to address new policy questions. Here we focus on new data on genomics, biomarkers, pathways, and the upcoming data from randomized controlled trials of flexible sigmoidoscopy screening.
In Aim 2 we apply our updated models to inform health policy, including evaluation of interventions across the cancer-control spectrum. New technologies and more individually tailored screening and treatment strategies will be evaluated with a special focus on health disparities.
In Aim 3 we disseminate results from our models to inform health policy, via methods that engage policy makers and encourage appropriate use of modeling in policy making and decision support. Here we envision innovation using open-access web-based model applications. We will begin with model extensions required for specific applications, with the balance of the work shifting heavily toward applications over the course of the funding period. Dissemination of our findings will occur throughout the funding period.
|van Hees, Frank; Zauber, Ann G; Klabunde, Carrie N et al. (2014) The appropriateness of more intensive colonoscopy screening than recommended in Medicare beneficiaries: a modeling study. JAMA Intern Med 174:1568-76|
|Lansdorp-Vogelaar, Iris; Fedewa, Stacey; Lin, Chun Chieh et al. (2014) Utilization of surveillance after polypectomy in the medicare population--a cohort study. PLoS One 9:e110937|
|Saini, Sameer D; van Hees, Frank; Vijan, Sandeep (2014) Smarter screening for cancer: possibilities and challenges of personalization. JAMA 312:2211-2|
|Cenin, Dayna R; St John, D James B; Ledger, Melissa J N et al. (2014) Optimising the expansion of the National Bowel Cancer Screening Program. Med J Aust 201:456-61|
|van Hees, Frank; Habbema, J Dik F; Meester, Reinier G et al. (2014) Should colorectal cancer screening be considered in elderly persons without previous screening? A cost-effectiveness analysis. Ann Intern Med 160:750-9|
|Lansdorp-Vogelaar, Iris; Gulati, Roman; Mariotto, Angela B et al. (2014) Personalizing age of cancer screening cessation based on comorbid conditions: model estimates of harms and benefits. Ann Intern Med 161:104-12|
|Hubbard, Rebecca A; Johnson, Eric; Hsia, Raymond et al. (2013) The cumulative risk of false-positive fecal occult blood test after 10 years of colorectal cancer screening. Cancer Epidemiol Biomarkers Prev 22:1612-9|
|Lansdorp-Vogelaar, Iris; Sharp, Linda (2013) Cost-effectiveness of screening and treating Helicobacter pylori for gastric cancer prevention. Best Pract Res Clin Gastroenterol 27:933-47|
|O'Mahony, James F; van Rosmalen, Joost; Zauber, Ann G et al. (2013) Multicohort models in cost-effectiveness analysis: why aggregating estimates over multiple cohorts can hide useful information. Med Decis Making 33:407-14|
|Etzioni, Ruth; Durand-Zaleski, Isabelle; Lansdorp-Vogelaar, Iris (2013) Evaluation of new technologies for cancer control based on population trends in disease incidence and mortality. J Natl Cancer Inst Monogr 2013:117-23|
Showing the most recent 10 out of 13 publications